Technical Analysis for AMPE - Ampio Pharmaceutical
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 15.73% | |
| Fell Below 50 DMA | Bearish | 15.73% | |
| MACD Bearish Centerline Cross | Bearish | 15.73% | |
| MACD Bearish Signal Line Cross | Bearish | 15.73% | |
| New Downtrend | Bearish | 15.73% | |
| 180 Bearish Setup | Bearish Swing Setup | 15.73% | |
| Expansion Breakdown | Bearish Swing Setup | 15.73% | |
| Expansion Pivot Sell Setup | Bearish Swing Setup | 15.73% | |
| Wide Range Bar | Range Expansion | 15.73% | |
| Wide Bands | Range Expansion | 15.73% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Gap Up Partially Closed | 2 minutes ago |
| Rose Above Lower Bollinger Band | about 1 hour ago |
| Gapped Up (Partial) | about 1 hour ago |
| Up 5% | about 1 hour ago |
| Up 3% | about 1 hour ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19; and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. The company is headquartered in Englewood, Colorado.
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Biopharmaceutical Pain Drug Discovery Arthritis Osteoarthritis Therapy Clinical Trial Covid 19 Treatment Of Osteoarthritis Ampion Ap 013 Ap 018 Ap 019
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Biopharmaceutical Pain Drug Discovery Arthritis Osteoarthritis Therapy Clinical Trial Covid 19 Treatment Of Osteoarthritis Ampion Ap 013 Ap 018 Ap 019
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.66 |
| 52 Week Low | 0.016 |
| Average Volume | 119,039 |
| 200-Day Moving Average | 0.0000 |
| 50-Day Moving Average | 0.2886 |
| 20-Day Moving Average | 0.2893 |
| 10-Day Moving Average | 0.2881 |
| Average True Range | 0.0372 |
| RSI | 31.03 |
| ADX | 26.19 |
| +DI | 18.3272 |
| -DI | 20.1966 |
| Chandelier Exit (Long, 3 ATRs) | 0.2858 |
| Chandelier Exit (Short, 3 ATRs) | 0.3316 |
| Upper Bollinger Bands | 0.3451 |
| Lower Bollinger Band | 0.2335 |
| Percent B (%b) | -0.12 |
| BandWidth | 38.5759 |
| MACD Line | -0.0028 |
| MACD Signal Line | 0.0008 |
| MACD Histogram | -0.0036 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.3400 | ||||
| Resistance 3 (R3) | 0.3533 | 0.3267 | 0.3200 | ||
| Resistance 2 (R2) | 0.3267 | 0.2961 | 0.3200 | 0.3133 | |
| Resistance 1 (R1) | 0.2733 | 0.2772 | 0.2600 | 0.2600 | 0.3067 |
| Pivot Point | 0.2467 | 0.2467 | 0.2400 | 0.2400 | 0.2467 |
| Support 1 (S1) | 0.1933 | 0.2161 | 0.1800 | 0.1800 | 0.1333 |
| Support 2 (S2) | 0.1667 | 0.1972 | 0.1600 | 0.1267 | |
| Support 3 (S3) | 0.1133 | 0.1667 | 0.1200 | ||
| Support 4 (S4) | 0.1000 |
